StockVS

NYSE · Medical Devices · USD

Owlet, Inc. (OWLT) Stock Analysis

Owlet, Inc. (OWLT) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

OWLT

$4.20

−$0.08 (−1.87%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare OWLT with… →

OWLT Key Statistics

As of Oct 21, 2026
Trading
Open
$4.30
Previous Close
$4.28
Day's Range
4.20–4.34
52-Week Range
4.09–16.94
Volume
78.37K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.91
Valuation
Market Cap
$122.73M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
19.09
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.07
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.54
Financials (FY)
Revenue (FY)
$105.71M+35.43%
Net Income (FY)
−$39.68M
Profit marginThe share of revenue left as profit after all costs and taxes.
−8.44%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
29.22M
1-Year Return
−51.33%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
189.55K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, OWLT closed at $4.20, −51.33% over 1 year.

Owlet, Inc. (OWLT) has a market capitalization of $122.73M.

In fiscal 2025, OWLT reported revenue of $105.71M.

OWLT Stock Return by Calendar Year

Owlet, Inc. (OWLT) return since Nov 2020: what $10,000 became

1 year
$10,000 $4,867
−51.33%
5 years
$10,000 $781
−92.19%
Since Nov 2020
$10,000 $309
−96.91%

If you had invested $10,000 in Owlet, Inc. (OWLT) at the close on November 5, 2020, the earliest close on record here, it would have been worth $309 at the close on October 21, 2026: −96.91% in total, −44.20% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−74.06%
2025+263.82%
2024−15.72%
2023−32.53%
2022−79.06%
2021−73.75%
2020 (partial year)+4.85%

As of October 21, 2026.

OWLT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$105.71M−$39.68M−37.5%
2024$78.06M−$12.54M−16.1%
2023$54.01M−$32.90M−60.9%
2022$69.20M−$79.34M−114.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$105.71M$53.53M−$8.26M−$39.68M−37.5%
2024$78.06M$39.31M−$20.22M−$12.54M−16.1%
2023$54.01M$22.59M−$28.63M−$32.90M−60.9%
2022$69.20M$23.31M−$84.62M−$79.34M−114.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

OWLT Valuation vs Medical Devices Median

Median of 145 stocks
MetricOWLTMedical Devices medianvs median
P/S ratio1.072.5358% below
Profit margin−8.44%−14.78%6.3 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 7 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Owlet, Inc. (OWLT) is capitalised at $122.73M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 108 employees.

The most recent close on file for OWLT is $4.20, dated October 21, 2026. That is −$0.08 (−1.87%) against the previous close. Over the past 52 weeks the price has ranged from $4.09 to $16.94. The latest close sits 2.69% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $105.71M. Against the prior fiscal year total of $78.06M, that is a change of +35.43%. The same year closed with a net loss of $39.68M. The reported profit margin is −8.44%. That is 6.3 percentage points above the Medical Devices median of −14.78%. Trailing earnings per share are −0.54.

Across the 4 fiscal years on file, revenue moves from $69.20M in 2022 to $105.71M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 19.09. The price-to-sales ratio is 1.07. On price-to-sales that is 57.59% below the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Over the trailing twelve months the total return is −51.33%. Across 5 years the annualized return works out at −39.94%. The reported beta is 1.91. Annualized volatility over the trailing 6 years is 84.4%.

Growth & Income

No dividend is on file for OWLT.

The strongest complete calendar year on file is 2025 at +263.82%; the weakest is 2022 at −79.06%. Of the 5 complete calendar years on file, 1 finished higher. 2026 is still running; the total return is −74.06% year to date.

Peer Comparison

Owlet, Inc. (OWLT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Owlet, Inc. OWLT $122.73M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Owlet, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Owlet, Inc.

Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents. It also provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxygen level, and sleep patterns; BabySat, which is intended for infants with conditions, including respiratory syncytial virus, pneumonia, bronchitis, croup, and other diagnoses; and Dream Sight, an audio and video monitor that enables parents to monitor their child. In addition, the company offers Dream Duo, which integrates Dream Sock and Dream Sight to create a connected health and safety system; Owlet360, a subscription service that provides personalized understanding of the babies' development, health, and sleep trends; and accessories, such as fabric accessory socks and the Owlet Sock Travel Case. The company was founded in 2012 and is headquartered in Lehi, Utah.

Visit website →